Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 15, 2021.
Article Versions
- You are currently viewing a Latest version of this article (July 15, 2021 - 04:00).
- latest version (September 1, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Attila Feher,
- Nabil E. Boutagy,
- Evangelos K. Oikonomou,
- Stephanie Thorn,
- Yi-Hwa Liu,
- Edward J. Miller,
- Albert J. Sinusas and
- Monique Hinchcliff
-
Sources of Support: Research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers R01 AR073270 (MH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT USA; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT USA; Department of Pharmacology, Yale School of Medicine, New Haven, CT USA; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT USA 5 Department of Biomedical Engineering, Yale University, New Haven, CT USA; Section of Rheumatology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT USA; Department of Internal Medicine, Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, CT USA.
Conflict of Interest: MH has received consulting fees from AbbVie and from Boehringer Ingelheim unrelated to the current study. EJM reports grant funding from NIH, Bracco, Eidos, Pfizer, and Alnylam as well as consulting fees from Bracco, Eidos, Pfizer, and Alnylam, all unrelated to the current study. AJS reports grant funding from Siemens and Jubilant as well as consulting fees from MicroVide, LLC, all unrelated to the current study.
Corresponding Author: Monique Hinchcliff, MD MS, Director, Yale Scleroderma Program, Yale School of Medicine, Section of Allergy, Rheumatology & Immunology, The Anlyan Center.